Ceryvyn Therapeutics Limited (ASX:CYV)

Ceryvyn Therapeutics Revenue

Ceryvyn Therapeutics had revenue of 1,000.00 AUD in the half year ending December 31, 2025, a decrease of -99.66%. This brings the company's revenue in the last twelve months to -20.12K. In the fiscal year ending June 30, 2025, Ceryvyn Therapeutics had annual revenue of 222.69K, down -43.29%.

• Revenue (ttm): -20.12K
• Revenue Growth: -43.29%
• P/S Ratio: -748.01
• Revenue / Employee: -609.61
• Employees: 33
• Market Cap: 15.05M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	222.69K	-169.99K	-43.29%
Jun 30, 2024	392.69K	-186.19K	-32.16%
Jun 30, 2023	578.88K	290.04K	100.42%
Jun 30, 2022	288.84K	161.37K	126.61%
Jun 30, 2021	127.46K	-18.38K	-12.60%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 3, 2026

Data Sources Report a data error